Eindhoven, Netherlands

Manfred Müller

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Manfred Müller: Innovator in Implantable Monitoring Devices

Introduction

Manfred Müller is a notable inventor based in Eindhoven, Netherlands. He has made significant contributions to the field of medical technology, particularly in the development of implantable devices for monitoring bodily functions. His innovative approach has the potential to enhance patient care and improve health outcomes.

Latest Patents

Müller's most recent patent is an implant device for in-body monitoring. This monitoring system includes an implantable intra-vascular support device designed to position against a vessel wall, along with an implantable sensor-actuator mounted to the support device. The sensor-actuator can transition between a non-deployed position, where it remains against the support device, and a deployed position, where it is displaced away from the support device. When deployed, the sensor generates signals that monitor flow away from the edge of a vessel. This system allows for flow monitoring without causing occlusion when not in use.

Career Highlights

Müller is associated with Koninklijke Philips Corporation N.V., a leading company in health technology. His work at Philips has allowed him to focus on innovative solutions that address critical health monitoring needs. His patent reflects his commitment to advancing medical technology and improving patient monitoring systems.

Collaborations

Müller has collaborated with notable colleagues, including Cornelis Petrus Hendriks and Mark Thomas Johnson. Their combined expertise contributes to the development of cutting-edge technologies in the medical field.

Conclusion

Manfred Müller is a distinguished inventor whose work in implantable monitoring devices showcases his dedication to innovation in healthcare. His contributions have the potential to significantly impact patient monitoring and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…